172 related articles for article (PubMed ID: 18646347)
1. AIDS-defining neoplasm prevalence in a cohort of HIV-infected patients, before and after highly active antiretroviral therapy.
Mayor AM; Gómez MA; Ríos-Olivares E; Hunter-Mellado RF
Ethn Dis; 2008; 18(2 Suppl 2):S2-189-94. PubMed ID: 18646347
[TBL] [Abstract][Full Text] [Related]
2. Mortality trends of HIV-infected patients after the introduction of highly active antiretroviral therapy: analysis of a cohort of 3,322 HIV-infected persons.
Mayor AM; Gómez MA; Ríos-Oliveras E; Hunter-Mellado RF
Ethn Dis; 2005; 15(4 Suppl 5):S5-57-62. PubMed ID: 16312941
[TBL] [Abstract][Full Text] [Related]
3. Frequency and distribution patterns of opportunistic infections associated with HIV/AIDS in Uganda.
Rubaihayo J; Tumwesigye NM; Konde-Lule J; Wamani H; Nakku-Joloba E; Makumbi F
BMC Res Notes; 2016 Dec; 9(1):501. PubMed ID: 27927247
[TBL] [Abstract][Full Text] [Related]
4. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.
Palella FJ; Baker RK; Moorman AC; Chmiel JS; Wood KC; Brooks JT; Holmberg SD;
J Acquir Immune Defic Syndr; 2006 Sep; 43(1):27-34. PubMed ID: 16878047
[TBL] [Abstract][Full Text] [Related]
5. The Changing Clinical Spectrum of Human Immunodeficiency Virus (HIV)-Related Oral Lesions in 1,000 Consecutive Patients: A 12-Year Study in a Referral Center in Mexico.
Ramírez-Amador V; Esquivel-Pedraza L; Sierra-Madero J; Anaya-Saavedra G; González-Ramírez I; Ponce-de-León S
Medicine (Baltimore); 2003 Jan; 82(1):39-50. PubMed ID: 12544709
[TBL] [Abstract][Full Text] [Related]
6. [Changes in the spectrum of morbidity and mortality in hospital admissions of HIV infected patients during the HAART era].
Escolano Hortelano CM; Ramos Rincón JM; Gutiérrez Rodero F; Masiá Canuto M; Hernández Aguado I; Benito Santaleocadia C; Padilla Urrea S; Martín-Hidalgo A
Med Clin (Barc); 2004 Jan; 122(1):1-5. PubMed ID: 14733866
[TBL] [Abstract][Full Text] [Related]
7. Cancer incidence and all-cause mortality in HIV-positive patients in Northeastern Algeria before and during the era of highly active antiretroviral therapy.
Chaabna K; Newton R; Vanhems P; Laouar M; Forman D; Boudiaf Z; Soerjomataram I
J Cancer Res Ther; 2016; 12(2):576-81. PubMed ID: 27461613
[TBL] [Abstract][Full Text] [Related]
8. Cancer in HIV-infected persons from the Caribbean, Central and South America.
Fink VI; Shepherd BE; Cesar C; Krolewiecki A; Wehbe F; Cortés CP; Crabtree-Ramírez B; Padgett D; Shafaee M; Schechter M; Gotuzzo E; Bacon M; McGowan C; Cahn P; Masys D;
J Acquir Immune Defic Syndr; 2011 Apr; 56(5):467-73. PubMed ID: 21239992
[TBL] [Abstract][Full Text] [Related]
9. Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review.
Cobucci RN; Lima PH; de Souza PC; Costa VV; Cornetta Mda C; Fernandes JV; Gonçalves AK
J Infect Public Health; 2015; 8(1):1-10. PubMed ID: 25294086
[TBL] [Abstract][Full Text] [Related]
10. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
11. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
Gingues S; Gill MJ
HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
[TBL] [Abstract][Full Text] [Related]
12. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
[TBL] [Abstract][Full Text] [Related]
13. Noninfectious pulmonary complications of HIV/AIDS.
Kanmogne GD
Curr Opin Pulm Med; 2005 May; 11(3):208-12. PubMed ID: 15818181
[TBL] [Abstract][Full Text] [Related]
14. Overview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: Implications for HAART use and NADM development.
Chiu CG; Smith D; Salters KA; Zhang W; Kanters S; Milan D; Montaner JSG; Coldman A; Hogg RS; Wiseman SM
BMC Cancer; 2017 Apr; 17(1):270. PubMed ID: 28410587
[TBL] [Abstract][Full Text] [Related]
15. The pattern of secondary cancers in patients with Kaposi sarcoma in the United States.
Kumar V; Garg M; Chaudhary N; Soni P; Floudas CS; Nwanyanwu C; Chandra A
Cancer Causes Control; 2017 Oct; 28(10):1065-1074. PubMed ID: 28900786
[TBL] [Abstract][Full Text] [Related]
16. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.
Martínez E; Milinkovic A; Buira E; de Lazzari E; León A; Larrousse M; Loncá M; Laguno M; Blanco JL; Mallolas J; García F; Miró JM; Gatell JM
HIV Med; 2007 May; 8(4):251-8. PubMed ID: 17461853
[TBL] [Abstract][Full Text] [Related]
17. Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005.
Yang CH; Huang YF; Hsiao CF; Yeh YL; Liou HR; Hung CC; Yang SY
HIV Med; 2008 Aug; 9(7):535-43. PubMed ID: 18554309
[TBL] [Abstract][Full Text] [Related]
18. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.
Lewden C; Salmon D; Morlat P; Bévilacqua S; Jougla E; Bonnet F; Héripret L; Costagliola D; May T; Chêne G;
Int J Epidemiol; 2005 Feb; 34(1):121-30. PubMed ID: 15561752
[TBL] [Abstract][Full Text] [Related]
19. Malignancies in HIV: pre- and post-highly active antiretroviral therapy.
Nutankalva L; Wutoh AK; McNeil J; Frederick WR; Reddy RB; Daftary M; Gentles A; Addae-Afoakwa K
J Natl Med Assoc; 2008 Jul; 100(7):817-20. PubMed ID: 18672558
[TBL] [Abstract][Full Text] [Related]
20. Toxoplasmic encephalitis in an AIDS cohort at Puerto Rico before and after highly active antiretroviral therapy (HAART).
Mayor AM; Fernández Santos DM; Dworkin MS; Ríos-Olivares E; Hunter-Mellado RF
Am J Trop Med Hyg; 2011 May; 84(5):838-41. PubMed ID: 21540399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
